 The Center for Proteomic Chemistry combines the integrated target class approaches with screening capabilities to generate high-quality leads for chemical optimization, in collaboration with Global Discovery Chemistry and all disease areas and platforms worldwide. The Center provides the Novartis research organization with compounds, tools, reagents and information that allows for the selection of novel, high quality lead and drug candidates. We contribute to the discovery of novel medicines through the use of breakthrough technologies and target-specific expertise.
| 
